Acadia Pharmaceuticals (ACAD) Property, Plant & Equipment (Net) (2010 - 2026)

Acadia Pharmaceuticals (ACAD) Property, Plant & Equipment (Net) (2010 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Property, Plant & Equipment (Net) (Qtr)
1	Oculis Holding AG	66,200.25 Bn	66,199.96 Bn	-	642,333.36
2	Nanobiotix	1,908.00 Bn	1,907.94 Bn	-	5.32 Mn
3	Akari Therapeutics	959.56 Bn	959.56 Bn	-	-
4	BeOne Medicines	471.75 Bn	466.96 Bn	1.35 Bn	1.64 Bn
5	Vertex Pharmaceuticals	121.94 Bn	114.69 Bn	2.59 Bn	1.61 Bn
6	Regeneron Pharmaceuticals	69.87 Bn	61.12 Bn	3.31 Bn	5.27 Bn
7	Belite Bio	62.43 Bn	62.43 Bn	-	-
8	Argenx Se	55.86 Bn	50.68 Bn	1.41 Bn	1.96 Bn
9	Alnylam Pharmaceuticals	37.49 Bn	34.48 Bn	959.66 Mn	518.26 Mn
10	Acadia Pharmaceuticals	4.35 Bn	3.50 Bn	243.27 Mn	14.65 Mn

Download Data